Results 11 to 20 of about 3,231,427 (376)

Novel Strategies for Fluorine‐18 Radiochemistry [PDF]

open access: yesAngewandte Chemie International Edition, 2011
Positron (b) emission tomography (PET) is a powerful, noninvasive tool for the in vivo, three-dimensional imaging of physiological structures and processes. PET imaging involves the incorporation of short-lived radionuclides, particularly carbon-11 and fluorine-18, into biologically active molecules.
Littich, Ryan, Scott, Peter J. H.
openaire   +6 more sources

A Fluorine-18 Radiolabeling Method Enabled by Rhenium(I) Complexation Circumvents the Requirement of Anhydrous Conditions. [PDF]

open access: yesChemistry, 2017
Azeotropic distillation is typically required to achieve fluorine-18 radiolabeling during the production of positron emission tomography (PET) imaging agents.
M. Klenner   +10 more
semanticscholar   +3 more sources

Fluorine-18 incorporation and radiometal coordination in macropa ligands for PET imaging and targeted alpha therapy. [PDF]

open access: yesChem Commun (Camb)
The development of theranostic agents for radiopharmaceuticals based on therapeutic alpha emitters marks an important clinical need. We describe a strategy for the development of theranostic agents of this type via the functionalization of the ligand ...
Kanagasundaram T   +5 more
europepmc   +3 more sources

Radiosynthesis of 5-[18F]Fluoro-1,2,3-triazoles through Aqueous Iodine–[18F]Fluorine Exchange Reaction

open access: yesMolecules, 2021
In this report, a simple and efficient process to achieve fluorine-18-labeled 1,2,3-triazole is reported. The heteroaromatic radiofluorination was successfully achieved through an iodine–fluorine-18 exchange in an aqueous medium requiring only trace ...
Xiang Zhang   +4 more
doaj   +1 more source

State of the art procedures towards reactive [18F]fluoride in PET tracer synthesis

open access: yesEJNMMI Radiopharmacy and Chemistry, 2023
Background Positron emission tomography (PET) is a powerful, non-invasive preclinical and clinical nuclear imaging technique used in disease diagnosis and therapy assessment. Fluorine-18 is the predominant radionuclide used for PET tracer synthesis.
Lizeth Y. F. Haveman   +2 more
doaj   +1 more source

Fully Automated, High-Dose Radiosynthesis of [18F]PARPi

open access: yesPharmaceuticals, 2022
[18F]PARPi is currently undergoing clinical trials as a PET tracer for many applications. However, only manual radiosynthesis was reported; this has several drawbacks, including an increased risk of contamination from the operator, and the need to limit ...
Anna Pacelli   +9 more
doaj   +1 more source

Isotopic Radiolabeling of the Antiretroviral Drug [18F]Dolutegravir for Pharmacokinetic PET Imaging

open access: yesPharmaceuticals, 2022
Deciphering the drug/virus/host interactions at infected cell reservoirs is a key leading to HIV-1 remission for which positron emission tomography (PET) imaging using radiolabeled antiretroviral (ARV) drugs is a powerful asset. Dolutegravir (DTG) is one
Marion Tisseraud   +9 more
doaj   +1 more source

Fluorine-18-Labeled Antibody Ligands for PET Imaging of Amyloid-β in Brain

open access: yesACS Chemical Neuroscience, 2020
Antibodies are attractive as radioligands due to their outstanding specificity and high affinity, but their inability to cross the blood–brain barrier (BBB) limits their use for CNS targets.
S. Syvänen   +7 more
semanticscholar   +1 more source

Advances in [18F]Trifluoromethylation Chemistry for PET Imaging

open access: yesMolecules, 2021
Positron emission tomography (PET) is a preclinical and clinical imaging technique extensively used to study and visualize biological and physiological processes in vivo.
Felix Francis, Frank Wuest
doaj   +1 more source

Home - About - Disclaimer - Privacy